- Home
- MSC vs TYRA Comparison
MSC vs TYRA Comparison
Compare MSC & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSC
- TYRA
- Stock Information
- Founded
- MSC 2000
- TYRA 2018
- Country
- MSC Hong Kong
- TYRA United States
- Employees
- MSC N/A
- TYRA N/A
- Industry
- MSC Hotels/Resorts
- TYRA Biotechnology: Pharmaceutical Preparations
- Sector
- MSC Consumer Discretionary
- TYRA Health Care
- Exchange
- MSC Nasdaq
- TYRA Nasdaq
- Market Cap
- MSC 766.5M
- TYRA 681.7M
- IPO Year
- MSC 2018
- TYRA 2021
- Fundamental
- Price
- MSC $3.93
- TYRA $13.39
- Analyst Decision
- MSC
- TYRA Strong Buy
- Analyst Count
- MSC 0
- TYRA 7
- Target Price
- MSC N/A
- TYRA $30.71
- AVG Volume (30 Days)
- MSC 46.1K
- TYRA 185.2K
- Earning Date
- MSC 11-04-2025
- TYRA 11-06-2025
- Dividend Yield
- MSC N/A
- TYRA N/A
- EPS Growth
- MSC N/A
- TYRA N/A
- EPS
- MSC N/A
- TYRA N/A
- Revenue
- MSC $679,264,000.00
- TYRA N/A
- Revenue This Year
- MSC $8.92
- TYRA N/A
- Revenue Next Year
- MSC N/A
- TYRA N/A
- P/E Ratio
- MSC N/A
- TYRA N/A
- Revenue Growth
- MSC 15.03
- TYRA N/A
- 52 Week Low
- MSC $2.30
- TYRA $6.42
- 52 Week High
- MSC $8.00
- TYRA $29.60
- Technical
- Relative Strength Index (RSI)
- MSC 51.79
- TYRA 59.58
- Support Level
- MSC $3.74
- TYRA $12.98
- Resistance Level
- MSC $4.00
- TYRA $13.92
- Average True Range (ATR)
- MSC 0.20
- TYRA 0.62
- MACD
- MSC 0.03
- TYRA 0.00
- Stochastic Oscillator
- MSC 89.02
- TYRA 55.66
About MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.